期刊文献+

脑脊液中Aβ检测对老年期痴呆早期诊断的意义 被引量:2

Significance of cerebrospinal fluid Aβ detect for A lzheimer's disease diagnosis in early stage
暂未订购
导出
摘要 目的 探讨脑脊液 (CSF)中 β -淀粉样蛋白 (Aβ)对老年性痴呆 (AD)的诊断价值。方法 采用双抗体夹心酶联免疫吸附法 (ELISA)检测 54例AD患者及 30例正常对照者 (NC)脑脊液中Aβ1 - 42 浓度。结果 CSF中Aβ1 - 42 平均浓度AD组为 (336 .0 83± 1 2 0 .1 80 )ng/L ,NC组为 (556 .967± 1 31 .341 )ng/L ;AD组CSF中Aβ1 - 42 浓度均明显低于NC组 (P <0 .0 5) ;检测CSF中Aβ1 - 42 浓度诊断AD的灵敏度为 46 .2 9% ,特异性为 92 .96 %。结论 临床上检测CSF中Aβ1 - 42 Objective It is to study the value of cerebrospina l fluid (CSF)β-amyl oid protein (Aβ) detect on diagnosis of Alzheimer's disease (AD) in early stag e. Methods The CSF Aβ 1-42 levels of 54 AD patients in AD group and 30 normal ca ses in control group were analyzed with sensitive enzyme-linked immunosorbent a ssays (ELISA). Results The mean levels of CSF Aβ 1-42 in AD group and cont rol group respectively were (336.083±120.180)ng/L and (556.967±131.341)ng/L. T he CSF Aβ 1- 42 level in AD group significantly lower than that in control group ( P <0.0 5). Th e sensitivity and specificity of AD diagnosis respectively were 46.29% and 92.96 %. Conclusion The AβCSF 1-42 is a clinical diagnostic mark er of AD in early stage.
出处 《现代中西医结合杂志》 CAS 2003年第8期789-790,792,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 国家劳动人事部回国人员基金资助项目 ( 1998- 58)
关键词 老年性痴呆 脑脊液 Β-淀粉样蛋白 Alzheimer's disease cerebrospinal fluid β-amyl oid protein
  • 相关文献

参考文献1

二级参考文献2

  • 1Cai X D,Science,1993年,254卷,514页
  • 2Kang J,Nature,1987年,325卷,733页

同被引文献31

  • 1毕胜,王德生,张昱,吴江,盛雨辰,赵庆杰,潘尚哈.血管性痴呆患者与其血浆同型半胱氨酸水平的关系[J].中华老年心脑血管病杂志,2000,2(5):318-321. 被引量:17
  • 2[15]Younkin SG. Amyloid beta vaccination: reduced plaques and improved cognition. Nat Med 2001;7(1): 18 -9
  • 3[16]Younkin SG. Amyloid beta vaccination: reduced plaques and improved cognition. Nat Med 2001;7(1): 18-9
  • 4[17]Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer' s disease. J Neurosci 2003; 23 (20): 7504 - 9
  • 5[1]Youkin SG, Evidence that A beta 42 is the real culprit Alzheimer' s disease.AnnNeurol 1995; 37(3): 287 - 8
  • 6[2]Hsiaok, chapamp, Nilse S, et al. Correlative Memory Deficits, Aβ. Elevation, and Amvloid plaoues in transgenic mice. Scicence 1996; 274;99
  • 7[4]Hook VY, Reisine TD. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway. J Neurosci Res2003; 74(3): 393 -405
  • 8[5]Combs CK, Karlo JC, Kao SC, et al. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 2001; 21 (4): 1179- 88
  • 9[6]Edbauer D, Winkler E, Haass C, et al. Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc Natl Acad Sci USA 2002; 99(13): 8666 -71
  • 10[7]Selkoe DT. Alzheimer' s disease: genotypes phenotype and treatments. Science1997; 275(5300): 630 - 1

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部